Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air® app
Background An innovation to better manage cat‐allergic patients utilises anti‐Fel d 1 IgY antibodies to neutralise Fel d 1 after its production by the cat. However, there is no published study showing its clinical efficacy in humans in a home setting. A longitudinal, open‐label, proof‐of‐concept stu...
Saved in:
| Published in: | Clinical and translational allergy Vol. 14; no. 5; pp. e12353 - n/a |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
John Wiley & Sons, Inc
01.05.2024
John Wiley and Sons Inc Wiley |
| Subjects: | |
| ISSN: | 2045-7022, 2045-7022 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!